Suppr超能文献

CRS 中嗅裂黏液炎症蛋白:一项病例对照研究。

Olfactory cleft mucus inflammatory proteins in CRS: a case-control study.

机构信息

Division of Rhinology and Sinus/Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR.

Division of Rhinology and Sinus Surgery, Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, SC.

出版信息

Int Forum Allergy Rhinol. 2021 Sep;11(9):1321-1335. doi: 10.1002/alr.22770. Epub 2021 Feb 24.

Abstract

BACKGROUND

Multiple hypotheses are evolving that suggest several, potentially overlapping etiologies for olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). Understanding inflammatory cytokine profiles of the olfactory cleft (OC) and their association with olfactory function is foundational for future clinical care and research.

METHODS

This cross-sectional, case-control study evaluates associations among OC mucus inflammatory proteins, psychophysical olfactory testing, and computed tomography (CT) analysis of the OC and sinuses. Normative reference intervals were determined for each protein and odds ratios (ORs) were used to compare proportions of altered expression between CRS without nasal polyposis (CRSsNP) and CRS without nasal polyposis (CRSwNP).

RESULTS

Case subjects with CRS (n = 151) and controls (n = 74) were evaluated. A majority of OC proteins tested were found within detectable ranges for cases and controls. The CRS cohort had significantly higher concentrations for 23 of 26 proteins. CRS cases with abnormal levels of C-C motif chemokine ligand 2 (CCL2), CCL3, interleukin 5 (IL5), IL10, and IL13 associated with greater olfactory deficits. The prevalence of elevated IL5 and IL13 in anosmic patients was 64.6% and 62.5%, respectively (p < 0.004). CRS cases with the highest odds of elevated expression in CRSwNP were IL5 (OR = 10.83) and IL13 (OR = 8.36). However, both IL5 and IL13 were still elevated in approximately 14% of CRSsNP patients. The highest magnitude of correlation between the total percent of OC opacification was found to be with IL5 (r = 0.543; p < 0.001), whereas other moderate correlations were noted with immunoglobulin E (IgE), IL10, and IL13.

CONCLUSION

This study confirmed that OC inflammatory proteins vary both by disease phenotype and in their association with OD. Type 2 inflammatory mediators are increased in CRS, especially within the CRSwNP group. However, a substantial proportion of CRSsNP also express type 2 inflammatory mediators. Further research is necessary to understand the complex roles OC mucous inflammatory proteins might play in defining endotype and in impacting CRS-related OD. ©2021 ARSAAOA, LLC.

摘要

背景

有多种假说表明,慢性鼻-鼻窦炎(CRS)患者的嗅觉功能障碍(OD)可能存在多种潜在重叠的病因。了解嗅裂(OC)中的炎症细胞因子谱及其与嗅觉功能的关系,是未来临床治疗和研究的基础。

方法

本横断面病例对照研究评估了 OC 黏液中炎症蛋白与嗅觉心理物理学测试和 OC 及鼻窦计算机断层扫描(CT)分析之间的关系。为每种蛋白确定了参考区间,并使用比值比(OR)比较了无鼻息肉的 CRS(CRSsNP)和无鼻息肉的 CRS(CRSwNP)之间表达改变的比例。

结果

共评估了 151 例 CRS 病例和 74 例对照。OC 中测试的大多数蛋白在病例和对照中均处于可检测范围内。CRS 组 26 种蛋白中的 23 种蛋白浓度显著升高。OC 中 C-C 基序趋化因子配体 2(CCL2)、CCL3、白细胞介素 5(IL5)、IL10 和 IL13 水平异常的 CRS 病例与更严重的嗅觉障碍相关。嗅觉丧失患者中 IL5 和 IL13 升高的患病率分别为 64.6%和 62.5%(p < 0.004)。在 CRSwNP 中,IL5(OR = 10.83)和 IL13(OR = 8.36)表达升高的 CRS 病例的可能性最高。然而,大约 14%的 CRSsNP 患者仍存在 IL5 和 IL13 升高。OC 完全不透明百分比与 IL5 之间的相关性最高(r = 0.543;p < 0.001),而与免疫球蛋白 E(IgE)、IL10 和 IL13 之间存在中度相关性。

结论

本研究证实,OC 炎症蛋白不仅因疾病表型而异,而且与 OD 相关。CRS 中 2 型炎症介质增加,尤其是在 CRSwNP 组中。然而,相当一部分 CRSsNP 也表达 2 型炎症介质。需要进一步研究以了解 OC 黏液炎症蛋白在确定表型和影响 CRS 相关 OD 方面可能发挥的复杂作用。©2021 ARSAAOA,LLC。

相似文献

1
Olfactory cleft mucus inflammatory proteins in CRS: a case-control study.
Int Forum Allergy Rhinol. 2021 Sep;11(9):1321-1335. doi: 10.1002/alr.22770. Epub 2021 Feb 24.
2
Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis.
Int Forum Allergy Rhinol. 2020 Mar;10(3):343-355. doi: 10.1002/alr.22499. Epub 2019 Dec 19.
3
Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis.
Laryngoscope. 2020 Oct;130(10):2311-2318. doi: 10.1002/lary.28332. Epub 2019 Oct 11.
4
Olfactory cleft computed tomography analysis and olfaction in chronic rhinosinusitis.
Am J Rhinol Allergy. 2016 Nov 1;30(6):402-406. doi: 10.2500/ajra.2016.30.4365.
5
Olfactory cleft mucus proteome in chronic rhinosinusitis: a case-control pilot study.
Int Forum Allergy Rhinol. 2021 Aug;11(8):1162-1176. doi: 10.1002/alr.22743. Epub 2020 Dec 4.
6
Volumetric computed tomography analysis of the olfactory cleft in patients with chronic rhinosinusitis.
Int Forum Allergy Rhinol. 2015 Sep;5(9):846-54. doi: 10.1002/alr.21552. Epub 2015 May 26.
7
Olfactory cleft mucus galectin-10 predicts olfactory loss in chronic rhinosinusitis.
Ann Allergy Asthma Immunol. 2023 Mar;130(3):317-324.e1. doi: 10.1016/j.anai.2022.07.014. Epub 2022 Jul 21.
8
Type 1/type 2 inflammatory cytokines correlate with olfactory function in patients with chronic rhinosinusitis.
Am J Otolaryngol. 2020 Sep-Oct;41(5):102587. doi: 10.1016/j.amjoto.2020.102587. Epub 2020 Jun 1.
9
Endotyping chronic rhinosinusitis based on olfactory cleft mucus biomarkers.
J Allergy Clin Immunol. 2021 May;147(5):1732-1741.e1. doi: 10.1016/j.jaci.2021.01.021. Epub 2021 Feb 4.
10
Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis.
Laryngoscope. 2018 Sep;128(9):E304-E310. doi: 10.1002/lary.27112. Epub 2018 Feb 8.

引用本文的文献

1
Mechanisms, diagnosis, and treatment of olfactory dysfunction in rhinosinusitis.
Eur J Med Res. 2025 Jun 11;30(1):474. doi: 10.1186/s40001-025-02740-y.
2
Role and Mechanism of Olfactory Stem Cells in the Treatment of Olfactory Disorders.
Stem Cells Int. 2025 Apr 24;2025:6631857. doi: 10.1155/sci/6631857. eCollection 2025.
3
Type 2 biomarkers in olfactory cleft mucus correlate with SNOT-22 in chronic rhinosinusitis independent of nasal polyp status.
Int Forum Allergy Rhinol. 2025 Apr;15(4):411-419. doi: 10.1002/alr.23503. Epub 2024 Dec 30.
5
Utilization of RNA sequencing to investigate olfactory dysfunction in chronic rhinosinusitis without nasal polyps: A pilot study.
World J Otorhinolaryngol Head Neck Surg. 2023 Jul 28;10(1):29-36. doi: 10.1002/wjo2.123. eCollection 2024 Mar.
6
Apoptosis and turnover disruption of olfactory sensory neurons in eosinophilic chronic rhinosinusitis.
Front Cell Neurosci. 2024 Feb 28;18:1371587. doi: 10.3389/fncel.2024.1371587. eCollection 2024.
8
IL-13 and IL-13-induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis.
J Allergy Clin Immunol. 2024 May;153(5):1292-1305. doi: 10.1016/j.jaci.2023.11.922. Epub 2023 Dec 28.
9
[Artificial intelligence-assisted prediction of olfactory disorders in patients with chronic rhinosinusitis].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Nov;37(11):871-877;885. doi: 10.13201/j.issn.2096-7993.2023.11.004.
10
Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study.
Eur Arch Otorhinolaryngol. 2024 Jan;281(1):219-226. doi: 10.1007/s00405-023-08184-6. Epub 2023 Aug 18.

本文引用的文献

1
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
J Allergy Clin Immunol. 2020 Sep;146(3):595-605. doi: 10.1016/j.jaci.2020.05.032. Epub 2020 Jun 7.
3
A case for multidisciplinary management of chronic rhinosinusitis with nasal polyposis.
Int Forum Allergy Rhinol. 2020 Jul;10(7):795-797. doi: 10.1002/alr.22557. Epub 2020 May 3.
4
Mechanisms and treatment of olfactory dysfunction in chronic rhinosinusitis.
Ann Allergy Asthma Immunol. 2020 Apr;124(4):307-308. doi: 10.1016/j.anai.2020.01.014. Epub 2020 Jan 30.
5
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.
Front Immunol. 2019 Dec 13;10:2759. doi: 10.3389/fimmu.2019.02759. eCollection 2019.
6
Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis.
Int Forum Allergy Rhinol. 2020 Mar;10(3):343-355. doi: 10.1002/alr.22499. Epub 2019 Dec 19.
7
Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis.
Laryngoscope. 2020 Oct;130(10):2311-2318. doi: 10.1002/lary.28332. Epub 2019 Oct 11.
9
Longitudinal stability of chronic rhinosinusitis endotypes.
Clin Exp Allergy. 2019 Dec;49(12):1637-1640. doi: 10.1111/cea.13502. Epub 2019 Oct 3.
10
Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis.
Int Forum Allergy Rhinol. 2019 Oct;9(10):1151-1158. doi: 10.1002/alr.22391. Epub 2019 Aug 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验